FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2899072002> ?p ?o ?g. }

• W2899072002 endingPage "418" @default.
• W2899072002 startingPage "418" @default.
• W2899072002 abstract "Lipophilic statins are promising candidates for breast cancer treatment. However, anticancer therapy requires much higher doses of statins than can be delivered orally, and such high doses are known to exert more adverse effects. The main objective of our study was to design a targeted, therapeutic liposomal carrier of simvastatin characterised by high stability and specificity towards breast cancer cells. We chose SKBR3, the cell line that showed the highest sensitivity for simvastatin and liposomal simvastatin treatment. Additionally, SKBR3 has a notably high expression level of human epidermal growth factor receptor 2 (HER2), which we used as a target for our immunoliposomes. To do so we attached humanized anti-HER2 antibody to the envelope of liposomes. We tested the stability and selectivity of the proposed formulation along with the toxicity, ability to induce apoptosis and the effect on signalling pathways involving Akt and Erk kinases. The immunoliposomal formulation of simvastatin is characterized by long-term stability, high selectivity towards HER2-overexpressing breast cancer cells, low non-specific cytotoxicity and effective inhibition of the growth of target cells, presumably by inhibition of signalling pathways and induction of apoptosis. Hence, for the first time, we propose the use of immunoliposomes with simvastatin, targeted directly towards breast cancer cells overexpressing HER2. The prepared immunoliposomes may become a proof of concept in developing new anticancer therapy." @default.
• W2899072002 created "2018-11-09" @default.
• W2899072002 creator A5028831413 @default.
• W2899072002 creator A5047985322 @default.
• W2899072002 creator A5071088128 @default.
• W2899072002 date "2018-11-01" @default.
• W2899072002 modified "2023-09-26" @default.
• W2899072002 title "Immunoliposomes with Simvastatin as a Potential Therapeutic in Treatment of Breast Cancer Cells Overexpressing HER2—An In Vitro Study" @default.
• W2899072002 cites W121236535 @default.
• W2899072002 cites W1774492603 @default.
• W2899072002 cites W1881092466 @default.
• W2899072002 cites W1970000720 @default.
• W2899072002 cites W1971837569 @default.
• W2899072002 cites W1980836878 @default.
• W2899072002 cites W1983729724 @default.
• W2899072002 cites W1988511889 @default.
• W2899072002 cites W1991742579 @default.
• W2899072002 cites W2003709444 @default.
• W2899072002 cites W2005826917 @default.
• W2899072002 cites W2006174096 @default.
• W2899072002 cites W2023934152 @default.
• W2899072002 cites W2035987019 @default.
• W2899072002 cites W2038338711 @default.
• W2899072002 cites W2047405239 @default.
• W2899072002 cites W2050240006 @default.
• W2899072002 cites W2051766316 @default.
• W2899072002 cites W2051818991 @default.
• W2899072002 cites W2051925512 @default.
• W2899072002 cites W2052988773 @default.
• W2899072002 cites W2070432942 @default.
• W2899072002 cites W2071455589 @default.
• W2899072002 cites W2076226743 @default.
• W2899072002 cites W2076598480 @default.
• W2899072002 cites W2080009224 @default.
• W2899072002 cites W2080518844 @default.
• W2899072002 cites W2086080480 @default.
• W2899072002 cites W2087688280 @default.
• W2899072002 cites W2099374439 @default.
• W2899072002 cites W2101642799 @default.
• W2899072002 cites W2113599025 @default.
• W2899072002 cites W2114941442 @default.
• W2899072002 cites W2118878458 @default.
• W2899072002 cites W2122513656 @default.
• W2899072002 cites W2126720685 @default.
• W2899072002 cites W2141393790 @default.
• W2899072002 cites W2145357526 @default.
• W2899072002 cites W2148027220 @default.
• W2899072002 cites W2149643076 @default.
• W2899072002 cites W2166045336 @default.
• W2899072002 cites W2166458266 @default.
• W2899072002 cites W2172081236 @default.
• W2899072002 cites W2179837550 @default.
• W2899072002 cites W2204324862 @default.
• W2899072002 cites W2205539453 @default.
• W2899072002 cites W2318605753 @default.
• W2899072002 cites W2407364089 @default.
• W2899072002 cites W2519084219 @default.
• W2899072002 cites W2560618623 @default.
• W2899072002 cites W2618974892 @default.
• W2899072002 cites W2778568826 @default.
• W2899072002 cites W2795652757 @default.
• W2899072002 cites W337728517 @default.
• W2899072002 cites W4238991694 @default.
• W2899072002 doi "https://doi.org/10.3390/cancers10110418" @default.
• W2899072002 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6266203" @default.
• W2899072002 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30388834" @default.
• W2899072002 hasPublicationYear "2018" @default.
• W2899072002 type Work @default.
• W2899072002 sameAs 2899072002 @default.
• W2899072002 citedByCount "20" @default.
• W2899072002 countsByYear W28990720022019 @default.
• W2899072002 countsByYear W28990720022020 @default.
• W2899072002 countsByYear W28990720022021 @default.
• W2899072002 countsByYear W28990720022022 @default.
• W2899072002 countsByYear W28990720022023 @default.
• W2899072002 crossrefType "journal-article" @default.
• W2899072002 hasAuthorship W2899072002A5028831413 @default.
• W2899072002 hasAuthorship W2899072002A5047985322 @default.
• W2899072002 hasAuthorship W2899072002A5071088128 @default.
• W2899072002 hasBestOaLocation W28990720021 @default.
• W2899072002 hasConcept C109316439 @default.
• W2899072002 hasConcept C121608353 @default.
• W2899072002 hasConcept C126322002 @default.
• W2899072002 hasConcept C185592680 @default.
• W2899072002 hasConcept C190283241 @default.
• W2899072002 hasConcept C191560914 @default.
• W2899072002 hasConcept C202751555 @default.
• W2899072002 hasConcept C2776329913 @default.
• W2899072002 hasConcept C2994423619 @default.
• W2899072002 hasConcept C502942594 @default.
• W2899072002 hasConcept C530470458 @default.
• W2899072002 hasConcept C55493867 @default.
• W2899072002 hasConcept C57074206 @default.
• W2899072002 hasConcept C62478195 @default.
• W2899072002 hasConcept C71924100 @default.
• W2899072002 hasConcept C96232424 @default.
• W2899072002 hasConcept C98274493 @default.
• W2899072002 hasConceptScore W2899072002C109316439 @default.

• next